Company Name	Benitec Biopharma Limited
Registered Office	Level 16, 356 Collins Street Melbourne, VIC 3000 Australia
Principal Place of Business	F6A/1-15 Barr Street Balmain, NSW 2041 Australia
Sector	Life Science / Biotechnology
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities	Biotechnology, research and development
Internet Homepage Address (URL)	http://www.benitec.com
Phone Number	(02) 9555 6986
Fax Number	(02) 9818 2238
Email Address	info@benitec.com
Financial Year End	30 June
Board of Directors	Mr Peter Francis, Non-Executive Chairman Dr John Chiplin, Non-Executive Director Mr Iain Ross, Non-Executive Director Mr Kevin Buchi, Non-Executive Director (Appointed on 11 April 2013) Dr Peter French MBA, PHD (Managing Director) (Stepped down as per announced on 9 December 2015) Mr Mel Bridges, Non-Executive Director (Resigned on 19 June 2014)
Management Team	Mr Greg West, Interim CEO (Appointed on 9 December 2015), CFO and Company Secretary Dr Michael Graham, Founding Scientist & Head of Discovery (Appointed June 2015) Dr David Suhy, Chief Scientific Officer (Appointed June 2015) Ms Georgina Kilfoil, Chief Clinical Officer (Appointed February 2015) Dr Craig Lewis, Chief Medical Adviser (Appointed on 17 March 2014) Dr Claudia Kloth, Vice President of Manufacturing (Appointed on 16 December 2014) Ms Annabel Murphy, Head of Investor Relations & Corporate Communications Dr Peter French MBA, PHD, Managing Director (Stepped down as per announced on 9 December 2015)
Company Secretary	Mr Greg West
Investor Relations Contact	Mr Greg West Mr Carl Stubbings Ms Annabel Murphy
Principal Bankers	Westpac Banking Corporation 274 Darling Street Balmain, NSW 2041 Australia
Auditors	Grant Thornton Audit Pty Ltd Level 17, 383 Kent Street Sydney, NSW 2000 Australia Phone: (61) 2 8297 2400 Fax: (61) 2 9299 4445 Email: info.nsw@au.gt.com Website: www.grantthornton.com.au
Legal Advisors	Francis Abourizk Lightowlers Level 16, 356 Collins Street Melbourne, VIC 3000 Australia
Share Registry	Computershare Investor Services Pty Limited Yarra Falls 452 Johnston Street Abbotsford, VIC 3067 Australia Phone : 1300 850 505 (from Australia) or              +61 3 9415 4000 (from overseas) Shareholders Enquiries: 1300 787 272
ASX Stock Symbol	BLT
Listing Date	17 February 1997
Shares on Issue	146,529,096 (as of 9 October 2015)
Number of Shareholders	3,126 (as of 10 August 2012)
Share Capital	A$2,662,914 (as of 30 June 2012) (Net equity)
Options Issued	18,477,742 (as of 11 March 2014)
Unlisted Options & Warrants	185,747,609 unlisted options and 6,126,962 warrants (as of 30 June 2013)
NASDAQ Listing	For ADSs - BNTC For warrants - BNTCW
US Sponsored ADR program	U.S Exchange : OTC CUSIP Number : 082053208 ISIN Number : US0820532085 ADR Ticker Symbol : BTEBY Level 1 ADR Ratio : 20:1 (Effective from 16 June 2015)
Cash and cash equivalents	$32,389,000 (as of 30 September 2015) $21,787,000 (as of 30 June 2015) $22,157,000 (as of 30 June 2015) $26,712,000 (as of 31 March 2015) $26,827,488 (as of 31 December 2014) $31.3 million (as of 30 June 2014) $18,402,000 (as of 31 March 2014)
Monthly Burn Rate	AUD$231,000 (as of 21 October 2013)
Capital Raised	Fund raising (net of costs) for the nine months to 31 March 2014 was $24.4 million That does not include a further $15.7 million raised in April 2014
Share Price	AUD$1.85 (at close of trade on 11 March 2014) AUD$0.30 (at close of trade on 11 March 2013)
Market Capitalisation	AUD$70.30 million (as of 9 October 2015) AUD$92.70 million (as of 29 May 2015) AUD$92.48 million (as of 2 February 2015) AUD$132.13 million (as of 15 July 2014) AUD$185.21 million (as of 11 March 2014) AUD$42.55 million (as of 12 December 2013) AUD$51.00 million (as of 12 November 2013) AUD$60.46 million (as of 21 October 2013) A$16.5 million (as of 28 August 2012)
Number of Staff	24 employees (as of 23 September 2015) [2012 : 5].
Year of Inception	2001
ABN	64 068 943 662